View in EDS HTML Full Text PDF Full Text

MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

Saved in:
Bibliographic Details
Title: MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.
Authors: Labrador, María1,2 (AUTHOR), Cozzubbo, Sara1,2 (AUTHOR), Porro, Mariangela1,2,3 (AUTHOR), Cumerlato, Michela1,2,4 (AUTHOR), Bandini, Cecilia1,2,5 (AUTHOR), Mereu, Elisabetta1,2,6 (AUTHOR), Paradzik, Tina3,7 (AUTHOR), Donati, Benedetta4,8 (AUTHOR), Manicardi, Veronica4,9 (AUTHOR), Ronchetti, Domenica1,5 (AUTHOR), D'Agostino, Mattia1,2,6 (AUTHOR), Larocca, Alessandra1,3,6 (AUTHOR), Gay, Francesca1,4,6 (AUTHOR), Bruno, Benedetto1,5,6 (AUTHOR), Ciarrocchi, Alessia4,6 (AUTHOR), Chatr-Aryamontri, Andrew7 (AUTHOR), Neri, Antonino5,8 (AUTHOR), Morelli, Eugenio8,9 (AUTHOR), Piva, Roberto1,2,6 (AUTHOR) roberto.piva@unito.it
Source: Cells (2073-4409). May2026, Vol. 15 Issue 9, p831. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20734409
DOI:10.3390/cells15090831